CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other disposition 10% owner disposed of 5,371,304 shares (other)
- 4 Returned to the company SVP Finance; Interim CFO & PAO returned 6.5 shares (to the company)
- 4 Returned to the company President & CEO returned 34.17 shares (to the company)
- 4 Returned to the company Director returned 28.23 shares (to the company)
- 4 Returned to the company 10% owner returned 6,266.52 shares (to the company)
- 4 Returned to the company Director returned 48.79 shares (to the company)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President & CEO bought 3,250 shares at $0.47 ($1,528)
- 4 Open-market buy SVP Finance; Interim CFO & PAO bought 3,250 shares at $0.47 ($1,528)
- 4 Open-market buy Chief Scientific Officer bought 3,250 shares at $0.47 ($1,528)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President & CEO bought 3,250 shares at $0.46 ($1,495)
- 4 Open-market buy SVP Finance; Interim CFO & PAO bought 3,250 shares at $0.46 ($1,495)
Page 7 of 37 · 739 filings